Health Care & Life Sciences » Pharmaceuticals | International Isotopes Inc.

International Isotopes Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
6,849.20
7,536.90
7,062.20
6,552.10
7,420.40
10,368.80
Cost of Goods Sold (COGS) incl. D&A
6,115.00
6,249.80
6,034.30
5,490.30
6,301.00
7,990.20
Gross Income
734.20
1,287.10
1,027.90
1,061.80
1,119.40
2,378.60
SG&A Expense
2,525.00
2,073.00
2,469.60
2,564.80
3,185.00
2,668.60
EBIT
1,790.90
785.90
1,441.70
1,503.00
2,065.60
290.10
Non Operating Income/Expense
284.50
86.50
24.00
6.60
256.40
86.80
Interest Expense
469.00
936.50
498.00
474.10
509.70
470.10
Pretax Income
2,485.60
1,539.20
1,826.00
1,895.50
3,722.30
663.90
Consolidated Net Income
2,485.60
1,539.20
1,826.00
1,895.50
3,722.30
663.90
Net Income
2,461.80
1,545.10
1,818.20
1,879.10
3,757.30
844.60
Net Income After Extraordinaries
2,461.80
1,545.10
1,818.20
1,879.10
3,757.30
844.60
Net Income Available to Common
2,461.80
1,545.10
1,818.20
1,879.10
3,757.30
844.60
EPS (Basic)
0.01
0.00
0.00
0.00
0.01
-
Basic Shares Outstanding
365,201.90
369,334.60
398,055.30
403,302.40
406,361.70
411,071.60
EPS (Diluted)
0.01
0.00
0.00
0.00
0.01
-
Diluted Shares Outstanding
365,201.90
369,334.60
398,055.30
403,302.40
406,361.70
411,071.60
EBITDA
1,375.20
522.40
1,221.40
1,266.90
1,815.30
7.20
Non-Operating Interest Income
1.10
0.60
0.40
0.90
3.10
9.40
Minority Interest Expense
23.70
5.80
7.80
16.40
35.00
180.60
Equity in Affiliates (Pretax)
57.70
96.10
89.30
74.00
893.70
-

About International Isotopes

View Profile
Address
4137 Commerce Circle
Idaho Falls Idaho 83401
United States
Employees -
Website http://www.intisoid.com
Updated 07/08/2019
International Isotopes, Inc. engages in the manufacture of nuclear medicine calibration and reference standards cobalt teletherapy sources, as well as radioisotopes and radiochemicals for medical research and clinical devices. It operates through the following segments: Radiochemical Products, Cobalt Products, Nuclear Medicine Products, Radiological Services, Fluorine Products, and Transportation. The Radiochemical Products segment includes production and distribution of various isotopically pure radiochemicals for medical, industrial, or research applications.